0,1,2,3,4,5,6,7,8
,Total number of complications,,,,Pneumonia,,,
,Univariate analysis,,Multivariate analysis,,Univariate analysis,,Multivariate analysis,
Variables,OR (95% CI),P value,OR (95% CI),P value,OR (95% CI),P value,OR (95% CI),P value
"Gender, male",0.8 (0.6–1.2),0.3,,,0.9 (0.6–1.3),0.5,,
6B/6B.1/6B.2 season,2.4 (1.7–3.4),<0.001,1.6 (1.0–2.8),0.05,2.5 (1.7–3.6),<0.001,1.78 (1.04–3.04),0.03
Age group,,<0.001,,0.01,,<0.001,,0.003
≤5,Reference,,Reference,,Reference,,Reference,
6–18,1.8 (1.1–2.9),0.03,2.1 (1.2–3.9),0.01,1.8 (1.1–3.1),0.03,2.6 (1.4–4.9),0.003
19–49,1.4 (0.9–2.3,0.17,2.04 (0.9–4.4),0.07,1.7 (1.0–2.9),0.05,2.5 (1.1–5.4),0.03
50–64,5.7 (3.1–10.5),<0.001,3.7 (1.3–10.3),0.01,6.9 (3.7–12.8),<0.001,4.04 (1.5–11.2),0.007
≥65,11.9 (5.3–26.8),<0.001,4.2 (1.2–14),0.02,15.2 (6.6–34.6),<0.001,5.7 (1.7–19.6),0.005
Onset to presentation,1.1 (1.0–1.2),0.008,1.05 (0.97–1.13),0.25,1.1 (1.04–1.2),0.003,1.05 (0.97–1.13),0.3
Underlying conditions,5.9 (3.97–8.9),<0.001,2.7 (1.45–5.04),0.002,6.5 (4.3–9.8),<0.001,2.9 (1.6–5.5),0.001
Obesity,6.6 (3.1–13.9),<0.001,2.53 (1.03–6.2),0.04,5.8 (2.8–11.8),<0.001,2.23 (0.9–5.4),0.08
Smoking,8.6 (3.9–18.7),<0.001,2.7 (0.8–9.1),0.1,8.5 (4.0–18.2),<0.001,2.15 (0.7–6.9),0.2
Alcoholism,13.3 (1.5–114.6),0.02,1.7 (0.1–19.6),0.7,15.2 (1.8–130.7),0.01,2.5 (0.3–0.1),0.47
Antiviral therapy,,<0.001,,<0.001,,<0.001,,<0.001
No antiviral therapy,Reference,,Reference,,Reference,,Reference,
Within 48 hours,3.7 (2.2–6.3),<0.001,2.7 (1.4–5.3),0.003,3.2 (1.9–5.6),<0.001,1.9 (0.93–3.8),0.08
After 48 hours,8.9 (5.2–15.1),<0.001,3.7 (1.9–7.1),<0.001,9.4 (5.4–16.3),<0.001,3.7 (1.9–7.2),<0.001
